Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
AbbVie
(NY:
ABBV
)
162.82
-1.74 (-1.05%)
Streaming Delayed Price
Updated: 10:50 AM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about AbbVie
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
54
55
Next >
7 Blue-Chip Stocks Smart Investors Should Be Loading Up on Now
August 14, 2023
These shares of blue-chip stocks to buy continue to be attractive for smart investors who value strong firms and steady performance.
Via
InvestorPlace
7 Dividend Stocks to Buy as Investor Sentiment Falters
August 14, 2023
With economic uncertainty rising, investors can ride out the potential storm with these dividend stocks to buy.
Via
InvestorPlace
How Revance Is Taking A Page Out Of AbbVie's Botox Playbook
August 14, 2023
The company sells a cosmetic treatment. Now, it's bridging into neuroscience.
Via
Investor's Business Daily
My Top Dividend King to Buy and Hold for the Next 10 Years, and It Isn't Even Close
August 14, 2023
This stock offers a high dividend yield, impressive dividend growth, and a lot more.
Via
The Motley Fool
3 Unstoppable Dividend Stocks to Buy Right Now
August 12, 2023
These stocks' dividends are more dependable than most.
Via
The Motley Fool
AbbVie Unusual Options Activity For August 11
August 11, 2023
Via
Benzinga
This Is What Whales Are Betting On AbbVie
August 09, 2023
Via
Benzinga
$100 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today
August 09, 2023
Via
Benzinga
Is AbbVie Stock a Buy for Income Investors?
August 04, 2023
The pharmaceutical giant is forecasting a return to growth starting in 2024.
Via
The Motley Fool
3 Pharma Stocks to Sell in August Before They Crash and Burn
August 11, 2023
Stay far away from these pharma stocks that are suffering from declining sales and weak pipelines of future products.
Via
InvestorPlace
3 Stocks That Recently Raised Their Guidance for the Year
August 09, 2023
These businesses have rosier outlooks for the future -- but that doesn't mean they're all slam-dunk buys right now.
Via
The Motley Fool
3 AI Stocks You’ll Regret Not Buying Soon
August 08, 2023
AI will have a big impact on biotech, which could help with drug discovery and create opportunities for these top AI stocks to invest in.
Via
InvestorPlace
Why Shares of Enanta Pharmaceuticals Are Dropping Tuesday
August 08, 2023
The company saw a slight revenue decline in its fiscal 2023 third-quarter earnings report.
Via
The Motley Fool
Is AbbVie Still a Good Dividend Stock to Buy?
August 08, 2023
Find out if AbbVie can overcome sinking sales of its top-selling product.
Via
The Motley Fool
Peering Into AbbVie's Recent Short Interest
August 03, 2023
Via
Benzinga
Check Out What Whales Are Doing With ABBV
August 02, 2023
Via
Benzinga
Got $5,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond
August 03, 2023
There's lots of upside potential for these drugmakers.
Via
The Motley Fool
3 High-Yielding Dividend Stocks to Buy and Hold for Decades
August 03, 2023
These are all solid businesses that could continue raising their dividend payments in the years ahead.
Via
The Motley Fool
Sell Alert: 3 Healthcare Stocks to Dump ASAP
August 03, 2023
These healthcare stocks to dump now will continue to be weighed down by legal issues and/or slumping sales.
Via
InvestorPlace
Better High-Yield Dividend Stock: AbbVie vs. Verizon Communications
August 01, 2023
Which of these high-yield dividend stocks is the better buy right now?
Via
The Motley Fool
Do Your Investments Pass the 5.45% Test? Here's How To Avoid Leaving Money On The Table
August 01, 2023
Imagine you're in a candy shop, and you have just enough money for one sweet treat. The problem? You're torn between a chocolate bar and a bag of gummy bears. That's when the principle of opportunity...
Via
Benzinga
3 Magnificent High-Yield Dividend Stocks to Buy Hand Over Fist in August
August 01, 2023
High yields aren't the only things these stocks offer.
Via
The Motley Fool
Amgen To Report Q2 Earnings: Here's What To Expect
July 31, 2023
Amgen will report second-quarter 2023 results on Aug. 3, after the market close.
Via
Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
July 31, 2023
Via
Benzinga
AbbVie, Pioneer Natural Resources And This Manufacturer Are CNBC's 'Final Trades'
July 31, 2023
On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management said AbbVie Inc.
Via
Benzinga
Here's Exactly How I'll Make Over $18,000 in Dividend Income This Year
July 30, 2023
Even investments with lower yields can generate significant dividend income.
Via
The Motley Fool
Is It Too Late to Buy InMode Stock?
July 30, 2023
Shares of the aesthetics industry's favorite medical technology provider are already up 64% over the past 12 months.
Via
The Motley Fool
Want $500 in Super Safe Annual Dividend Income? Invest $9,900 in the Following 3 Dividend Kings
July 30, 2023
These truly rock-solid income stocks, which sport an average yield of 5.07%, can pad patient investors' wallets.
Via
The Motley Fool
3 Stocks Retirees Should Absolutely Love
July 29, 2023
These stocks offer solid income plus more.
Via
The Motley Fool
3 Biotech Stocks to Buy Before Drug Trials End
July 28, 2023
Drug trials are a chance for high risk, high reward investing. These stocks doing neurodegenerative trials could be set for big gains.
Via
InvestorPlace
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
54
55
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.